Sagard
Sagard is a French private equity firm founded in 2002 as Sagard SAS, the Paris-based principal investments arm of Power Corporation of Canada's broader alternative investments platform. Sagard invests in European mid-market companies through dedicated buyout vehicles (Sagard 1 through 5, Sagard Mid Cap and Sagard NewGen), with focus on Industrials, Healthcare, Business Services, Consumer and TMT. The Paris team operates as part of Sagard Holdings, a multi-strategy alternative asset manager with global AUM of approximately US$45 billion as of December 31, 2025.
Sagard is a Paris buyout firm with €25.0B AUM, 24 active companies and 13 exits.
- ·6 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 12 realized deals: 4 years.
Sector breakdown
37 companiesGeography breakdown
3 geographiesKey facts
Recent exits
Sagard sold Climater to Intermediate Capital Group in 2025 after 3 years.
Sagard sold Sterimed to IK Partners in 2025 after 6 years.
Sagard sold I-tracing to Eurazeo Continuation Fund and Oakley Capital in 2024 after 3 years.
Coverage notes
1 fund tracked, 37 portfolio companies (24 active · 13 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Sagard has raised, with its portfolio companies. Hand-checked from public filings.
SagardBuyout2002€2.5B24 assets13 exitsBuyout2002 · 24yr€2.5B2413
Unrealized
24 held| Company | Entry |
|---|---|
| ADIT Group Business Services · France | 2026 |
| Asobo Studio Gaming · France | 2021 |
| Audensiel Business Services · France | 2022 |
| CEPL Business Services · France | 2005 |
| Ceva Pharma · France | 2010 |
| DiliTrust LegalTech · France | 2022 |
| EOS Corrugated Industrials · France | 2021 |
| Essences & Parfums Consumer · France | 2026 |
| FuturMaster (Sunstice) Software · France | 2024 |
| Ginger Construction · France | 2021 |
| Grand Frais Consumer · France | 2016 |
| Groupe Acceo Business Services · France | 2024 |
| Groupe Destaing Healthcare · France | 2021 |
| Groupe Synov Industrials · France | 2023 |
| GV3-Venpa Business Services · Italy | 2024 |
| Horizon Software TMT · France | 2022 |
| Kbrw SaaS · France | 2024 |
| kShuttle Data & Analytics · France | 2024 |
| Novepan Consumer · France | 2022 |
| Primelis AdTech · France | 2024 |
| Quipment Healthcare · France | 2026 |
| Sabena Technics Aerospace & Defence · France | 2019 |
| Safic-Alcan Industrials · France | 2015 |
| Unit8 TMT · France | 2022 |
Realized
13 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Aliplast Construction · Belgium | 2006 | 2014 | Secondary | Advent International | – |
| Alvest Aerospace & Defence · France | 2015 | 2018 | Secondary | CDPQ + Ardian | – |
| Cérélia Consumer · France | 2011 | 2015 | Secondary | Capza | – |
| Climater Business Services · France | 2022 | 2025 | Secondary | Intermediate Capital Group | – |
| Corialis Construction · Belgium | 2007 | 2014 | Secondary | Advent International | – |
| I-tracing Cybersecurity · France | 2021 | 2024 | Continuation Vehicle | Eurazeo Continuation Fund and Oakley Capital | – |
| Invoke TMT · France | 2021 | 2023 | Trade Sale | Regnology | – |
| Kiloutou Construction · France | 2018 | 2018 | Secondary | HLDI and HLD Europe | – |
| Laboratoires Delbert Pharma · France | 2022 | 2023 | Recapitalization | Vivalto Partners | – |
| Nutrisens FoodTech · France | 2021 | 2025 | Secondary | Cinven | – |
| RLD Business Services · France | 2006 | 2013 | Secondary | Vermeer Capital | – |
| Souriau Aerospace & Defence · France | 2006 | 2011 | Trade Sale | Esterline Technologies | – |
| Sterimed MedTech · France | 2019 | 2025 | Secondary | IK Partners | – |
About Sagard
Sagard is a French private equity firm founded in 2002 as Sagard SAS, the Paris-based principal investments arm of Power Corporation of Canada's broader alternative investments platform. The Paris team operates as part of Sagard Holdings, a multi-strategy alternative asset manager with global AUM of approximately US$45 billion as of December 2025 across venture capital, private equity, private credit, real estate and private wealth management. Sagard SAS specifically focuses on European mid-market private equity through successive flagship vintage funds.
Investment thesis
Sagard targets European mid-market companies, primarily France-headquartered, across Industrials, Healthcare, Business Services, Consumer and TMT sectors. The firm deploys capital from successive vintage funds (Sagard 1 through 5, Sagard Mid Cap and Sagard NewGen) into majority and significant minority stakes in profitable businesses with strong management teams and scale-up potential. Equity ticket sizes typically range from €40 million to €200 million per transaction across the platform's vintage funds.
Recent activity
Active portfolio companies include Kiloutou (industrials, equipment rental, since 2018), I-TRACING (cybersecurity services, since 2021), Cerelia (consumer, frozen dough products), Asobo Studio (TMT, video games studio behind Microsoft Flight Simulator), Horizon Software (TMT, electronic trading platforms) and Laboratoires Delbert (healthcare, pharmaceutical reintroductions). Historical realised exits include Alvest (2018), Cerelia (2015), Souriau (2011) and Corialis (2014).
Portfolio platforms backed by Sagard made 3 researched add-on acquisitions during its ownership.
Frequently asked questions
- What investment strategy does Sagard focus on?
- Sagard focuses on Buyout strategies in the private equity space.
- How many portfolio companies does Sagard have?
- Sagard has 24 active portfolio companies and 13 completed exits and 1 fund tracked on GP Intel.
- Where is Sagard headquartered?
- Sagard is headquartered in Paris, France.
- What is Sagard's assets under management?
- Sagard manages approximately €25.0B in assets under management.
- When was Sagard founded?
- Sagard was founded in 2002.
- What sectors does Sagard invest in?
- Sagard invests across Industrials, Healthcare, Business Services, Consumer, TMT.
- What are Sagard's recent exits?
- Recent realized exits by Sagard include: Climater (2025) to Intermediate Capital Group; Nutrisens (2025) to Cinven; Sterimed (2025) to IK Partners; I-TRACING (2024) to Eurazeo Continuation Fund and Oakley Capital; Invoke (2023) to Regnology; Laboratoires Delbert (2023) to Vivalto Partners; Alvest (2018) to CDPQ + Ardian; Kiloutou (2018) to HLDI and HLD Europe.
Similar firms
Other private equity firms tracked on GP Intel.